Further trials of a vaccine against American cutaneous leishmaniasis.

Suppr

超能文献

作者信息

Mayrink W, Antunes C M, Da Costa C A, Melo M N, Dias M, Michalick M S, Magalhães P A, De Oliveira Lima A, Williams P

出版信息

Trans R Soc Trop Med Hyg. 1986;80(6):1001. doi: 10.1016/0035-9203(86)90296-8.

DOI:10.1016/0035-9203(86)90296-8

PMID:3299899

Abstract

摘要

相似文献

Further trials of a vaccine against American cutaneous leishmaniasis.

Trans R Soc Trop Med Hyg. 1986;80(6):1001. doi: 10.1016/0035-9203(86)90296-8.

Second-generation vaccines against leishmaniasis.

Trends Parasitol. 2005 May;21(5):244-9. doi: 10.1016/j.pt.2005.03.006.

Not All Antigens Are Created Equally: Progress, Challenges, and Lessons Associated with Developing a Vaccine for Leishmaniasis.

Clin Vaccine Immunol. 2017 Jul 5;24(7). doi: 10.1128/CVI.00108-17. Print 2017 Jul.

Recombinant DNA-derived leishmania proteins: from the laboratory to the field.

Lancet Infect Dis. 2005 Feb;5(2):107-14. doi: 10.1016/S1473-3099(05)01282-X.

DNA based vaccination with a cocktail of plasmids encoding immunodominant Leishmania (Leishmania) major antigens confers full protection in BALB/c mice.

Vaccine. 2009 Jan 1;27(1):99-106. doi: 10.1016/j.vaccine.2008.10.013. Epub 2008 Oct 23.

Vaccines for leishmaniasis: from proteome to vaccine candidates.

Hum Vaccin. 2011 Jan-Feb;7 Suppl:10-5. doi: 10.4161/hv.7.0.14556. Epub 2011 Jan 1.

Identifying vaccine targets for anti-leishmanial vaccine development.

Expert Rev Vaccines. 2014 Apr;13(4):489-505. doi: 10.1586/14760584.2014.894467.

Protective immunity against cutaneous leishmaniasis achieved by partly purified vaccine in a volunteer.

Lancet. 1986 Jun 28;1(8496):1490. doi: 10.1016/s0140-6736(86)91516-3.

Controlled field trials of a vaccine against New World cutaneous leishmaniasis.

Int J Epidemiol. 1986 Dec;15(4):572-80. doi: 10.1093/ije/15.4.572.

A comparison of the molecular biology of trypanosomes and leishmaniae, and its impact on the development of methods for the diagnosis and vaccination of leishmaniasis and Chagas disease.

Biol Res. 1993;26(1-2):219-24.

引用本文的文献

Leishmaniasis: current status of vaccine development.

Clin Microbiol Rev. 2001 Apr;14(2):229-43. doi: 10.1128/CMR.14.2.229-243.2001.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Further trials of a vaccine against American cutaneous leishmaniasis.

Trans R Soc Trop Med Hyg. 1986;80(6):1001. doi: 10.1016/0035-9203(86)90296-8.

Second-generation vaccines against leishmaniasis.

Trends Parasitol. 2005 May;21(5):244-9. doi: 10.1016/j.pt.2005.03.006.

Not All Antigens Are Created Equally: Progress, Challenges, and Lessons Associated with Developing a Vaccine for Leishmaniasis.

Clin Vaccine Immunol. 2017 Jul 5;24(7). doi: 10.1128/CVI.00108-17. Print 2017 Jul.

Recombinant DNA-derived leishmania proteins: from the laboratory to the field.

Lancet Infect Dis. 2005 Feb;5(2):107-14. doi: 10.1016/S1473-3099(05)01282-X.

DNA based vaccination with a cocktail of plasmids encoding immunodominant Leishmania (Leishmania) major antigens confers full protection in BALB/c mice.

Vaccine. 2009 Jan 1;27(1):99-106. doi: 10.1016/j.vaccine.2008.10.013. Epub 2008 Oct 23.

Vaccines for leishmaniasis: from proteome to vaccine candidates.

Hum Vaccin. 2011 Jan-Feb;7 Suppl:10-5. doi: 10.4161/hv.7.0.14556. Epub 2011 Jan 1.

Identifying vaccine targets for anti-leishmanial vaccine development.

Expert Rev Vaccines. 2014 Apr;13(4):489-505. doi: 10.1586/14760584.2014.894467.

Protective immunity against cutaneous leishmaniasis achieved by partly purified vaccine in a volunteer.

Lancet. 1986 Jun 28;1(8496):1490. doi: 10.1016/s0140-6736(86)91516-3.

Controlled field trials of a vaccine against New World cutaneous leishmaniasis.

Int J Epidemiol. 1986 Dec;15(4):572-80. doi: 10.1093/ije/15.4.572.

A comparison of the molecular biology of trypanosomes and leishmaniae, and its impact on the development of methods for the diagnosis and vaccination of leishmaniasis and Chagas disease.

Biol Res. 1993;26(1-2):219-24.

引用本文的文献

Leishmaniasis: current status of vaccine development.

Clin Microbiol Rev. 2001 Apr;14(2):229-43. doi: 10.1128/CMR.14.2.229-243.2001.